Mitigating Study Power Loss Caused by Clinical Trial Disruptions Due to the COVID-19 Pandemic: Leveraging External Data via Propensity Score-Integrated Approaches
Statistics in Biopharmaceutical Research
; : 1-9, 2020.
Article
in English
| Taylor & Francis | ID: covidwho-977346
Full text:
Available
Collection:
Databases of international organizations
Database:
Taylor & Francis
Type of study:
Prognostic study
/
Randomized controlled trials
Language:
English
Journal:
Statistics in Biopharmaceutical Research
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS